There's more to Merck's Ebola vaccine than money

A vaccine being developed by Merck and NewLink was shown to be 100 percent effective, but does this mean they'll make big bucks?
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.